BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chu KKW, Chok KSH. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients? World J Gastroenterol 2019; 25(27): 3563-3571 [PMID: 31367157 DOI: 10.3748/wjg.v25.i27.3563]
URL: https://www.wjgnet.com/1948-5182/full/v25/i27/3563.htm
Number Citing Articles
1
Zainul Abedin Kapacee, Mairéad G. McNamara, Nicola de Liguori Carino, Angela Lamarca, Juan W. Valle, Richard A. Hubner. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare?European Journal of Surgical Oncology 2021; 47(3): 583 doi: 10.1016/j.ejso.2020.03.210
2
Piera Federico, Emilio Francesco Giunta, Annalisa Pappalardo, Andrea Tufo, Gianpaolo Marte, Laura Attademo, Antonietta Fabbrocini, Angelica Petrillo, Bruno Daniele. How to Treat Hepatocellular Carcinoma in Elderly PatientsPharmaceuticals 2021; 14(3): 233 doi: 10.3390/ph14030233
3
Jihye Lim, Kyung Won Kim, Yousun Ko, Il-Young Jang, Yung Sang Lee, Young-Hwa Chung, Han Chu Lee, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Jonggi Choi, Danbi Lee. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACEBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08905-2